Leptin-E100, the obese 
        protein
  Josephine Comas Bardot '08 and Ryan Ruffing '07 
   
Contents:
    
I. Introduction
Leptin, represented here as the Leptin E-100 mutant, is the product 
  of the obesity gene (OB)   discovered 
  in 1994 by Zhang et al . Leptin is responsible for the ob/ob phenotype 
  in obese mice.  Although leptin is commonly present as its wild type, 
  it can only be crystallized in the E-100 mutant form which substitutes glutamine 
  for tryptophan at position 100 . This mutation 
  has a minimal effect on the structure or function of the protein. The structure 
  of leptin resembles the members of the long chain helical cytokine family, which 
  are proteins that interact directly with specific cell surface receptors. Leptin, 
  produced in adipocytes, circulates through the blood stream and provides the 
  central nervous system (CNS) with a signal for energy intake and energy storage 
  in the body. Leptin is more abundant when energy intake and storage are high, 
  and less abundant when energy intake and storage are low. Thus when wild type 
  leptin and wild type leptin receptors are present, the CNS will work with the 
  hypothalamus to regulate appetite and maintain body weight according to the 
  signal.  
The signalling interaction between leptin and the hypothalamus is regulated 
  by specific interactions between the protein and the leptin receptor Ob-Rb. 
  Leptin receptors are expressed throughout the CNS, including the hypothalamus, 
  and other body tissues. Ob-Rb and other leptin receptors that represent different 
  splices of the same gene expressed throughout the body (Ob-Ra, Ob-Rc, Ob-Rd, 
  Ob-Re, Ob-Rf), are part of the class I cytokine receptor family. The binding 
  of leptin to Ob-Rb activates the signaling of transducer and activator of transcription 
  (STAT) proteins that regulate the expression of neuronal genes affecting appetite. 
  The hypothalamus is considered to be the main location for energy intake regulation; 
  however, other parts of the brain can function similarly when exposed to leptin. 
  
The continued study of leptin has focused on understanding obesity, 
  diabetes, and cardiovascular disease in humans. Most of the research unfortunately 
  can only use the mouse as a model which presents obstacles in understanding 
  the function of leptin in humans. While obesity in mice can be cured by artificially 
  increasing leptin levels in the blood stream, obese humans are resistant to 
  similar treatments. In other words, obesity in mice is the result of mutations 
  in the OB gene which render leptin inactive. However, obesity in humans, appears 
  to be the result of the inability to transport leptin into CNS cells. PLEASE ACTIVATE LEPTIN RESTORE MODE  
  
  
 
II. General Structure
The obese gene codes for a leptin molecule that is 167 amino acids 
  in length, and includes a secretory signal sequence that is 21 amino acids in 
  length.  Thus, the protein that circulates in the body and contacts the 
  CNS along with other body tissues is 146 amino acids long and 16 kDa in weight.  
  This is the protein displayed here.  The secondary structure of leptin 
  is most obviously characterized by a four helix bundle which adopts an unusual 
  up-up-down-down fold   . The four helices: αA , αB 
    , αC , and 
  αD  relate to 
  form an antiparallel left twisted helical bundle. This left hand twisted arrangement 
  of the four helices is antiparallel because in each of the two stacks there 
  is an up oriented helix and a down oriented helix (A 
  and D against B and 
  C).  Please Restore 
  Leptin  .  
  
Four loop structures join the helices.  The AB 
  loop  is an extended 
  loop which allows helix B to run in the same direction as helix A; 
  loop BC  is short 
  and facilitates the antiparallel BC stack; and the CD 
  loop    is long 
  which allows C and D to both extend in the downward direction.  The CD 
  loop also includes the short and distorted helix E . 
  Please Restore Leptin   .
A large hydrophobic  core of the protein runs through the center of the helix bundle and is  maintained by the conserved regions of αA
  , αB
  , αC
  , and αD
  .  These conserved regions  relate as they face each other in the interior of the bundle
  .  Helix E also plays an essential role in the  creation of this hydrophobic core, by capping it. Please Restore Leptin 
  .
Conserved residues from the CD loop which  mostly reside in Helix E (Leu 104, Leu 107, Leu 110, Leu 114, and Val 113)
    , are packed closely to residues in Helix B (Val 60, Ile 64, and Met  68)
     and Helix D (Val 124, and Ala 125)
     that are hydrophobic  in nature  This hydrophobic cap serves to  further stabilize the core of the protein as well as to hide lipophilic  residues that reside on the B and D helices.  Please Restore Leptin 
    .        
 III. Leptin Receptors
Leptin receptors are members of the class I cytokine receptor family. 
  Class I cytokine receptors do not have activity inside the cell therefore we 
  say they do not have endogenous kinase activity. These receptors instead have 
  janus kinase (JAK) activity that phosphorylates the tyrosines 
  within Ob-Rb . Furthermore, the binding of leptin to its receptor causes the 
  phosphorylation of the STAT protein . The phosphorylation of the STAT proteins 
  results in the activation of transcription of the neuronal genes associated 
  with appetite and body weight management, and completes the JAK/STAT pathway. 
  Studies have shown that the activation of the phosphatidulinositol 3-kinase 
  and phosphodiesterase 3B are necessary prior to the activation of the STAT proteins. 
  The five other Ob receptors found in other cells and tissues lack the STAT protein 
  binding, thus they are unable to activate STAT signaling. These receptors intead 
  activate the JAK 2 and the mitogen-activated kinase, however, little is known 
  about the physiological significance of the activation of this kinase. The Ob-Ra 
  is better understood and it has been demonstrated that this receptor's function 
  is to transport leptin across the blood/cerebrospinal fluid barrier in the choroid 
  plexus. Further studies have shown that the Ob-Re receptor acts as a leptin 
  binding protein to activate a second protein binding, which prolongs the half-life 
  of leptin. 
 
 IV. Receptor Binding 
 The majority of knowledge we have about leptin receptor binding is 
  derived from leptin's structural similarity to other long-chain helical cytokines. 
  Though the sequences in this family of proteins differ significantly their structures 
  are highly superimposible. Leptin receptor binding has been elucidated largely 
  by this method of comparison because the complex of leptin and Ob-Rb has not 
  yet been demonstrated. Within regions where other proteins of this family bind 
  their receptors, key differences have been shown that are understood to be important 
  in leptin binding of Ob-Rb. The first of these structural differences is the 
  small kink in the last turn of helix D which is thought to accomodate the specific 
  structure of leptin's receptors . Also in 
  this same vicinity of the protein the end of helix B is about two turns shorter 
  that in its family counterparts. The unique section at the N terminus of the 
  D helix has also been understood as playing a key role in receptor binding . When two conserved cysteine residues, one at the N terminus of the protein 
  and the other on the CD loop are eliminated receptor binding can not be accomplished 
      . The disulfide bonding between these two residues is accomodated by the sharp 
  36 degree kink in the end of the D helix  . Please 
  Restore Leptin  . Finally, 
  there is a section of the AB loop that is distorted in the crystal structure 
  and that remains undefined structurally . It is distorted 
  in the structure because it is a very flexible region. This is known because 
  similar flexible regions exist in other proteins of the family and have been 
  stabilized in the event of receptor binding. Thus this region is believed to 
  play a key role in the binding of Ob-Rb by leptin. 
 V. Leptin Induced Signaling 
The study of leptin has revealed that this protein 
  is involved in many different physiological processes besides its key role in 
  weight homeostasis. Although many physiological pathways are controled by the 
  CNS, the presence of leptin and its receptors throughout the entire body suggests 
  that the protein is able to directly affect other cells and tissues. Ongoing 
  studies have suggested that levels of leptin and proper leptin receptor expression 
  control the possibilities for cardiovascular risk, platelet aggregation, hypertension, 
  oxidative stress, anguigenesis, and thrombosis. Furthermore, 
  leptin appears to have functions related to the immune system as it is present 
  in many different immune system cells like macrophages and other bone marrow 
  cells. Leptin works closely with insulin sensitivity to directly and indirectly 
  affect energy intake. Just like leptin, insulin increases the activation of 
  STAT3 and myogen-activated kinase activity explaining how leptin may influence 
  insulin action on tissues. Other studies have shown how leptin stimulates lypolysis 
  in white adipose tissues which results in the stimulation of the oxidation of 
  fatty acids within the adipocytes. Although not fully understood, observations 
  of the activity of leptin have suggested that leptin may have functions relating 
  to reproduction. Leptin's ability to control energy intake may play a crucial 
  role in fetal growth and development, ovarian steroidogenesis, and placental 
  function. 
 V. References
Crystal Structure Information:
Zhang, Faming, et al. 1997. Crystal structure of the obese protein leptin-E100. 
  Nature 387:206-209. 
Physiological Background Information:
Prolo, Paolo, et al. 1998. Molecules in focus Leptin. The International Journal of Biochemistry & Cell Biology. 30: 1285-1290.
Considine, Robert V. 2005. Human Leptin: An Adipocyte Hormone with Weight-Regulatory and Endocrine Functions. Seminars in Vascular Medicine 5: 15-24.
Diamond, Frank B., et al. 1997.  Demonstration of a Leptin Binding Factor in Human Serum.  Biochemical and Biophysical research communications 233: 818-822.